MRI-Based Radiomic Models Outperform Radiologists in Predicting Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
Open Access
- 2 February 2023
- journal article
- research article
- Published by Elsevier in Academic Radiology
- Vol. 30, S176-S184
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Dynamic contrast‐enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancerJournal of Magnetic Resonance Imaging, 2015
- Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo‐adjuvant chemoradiationJournal of Magnetic Resonance Imaging, 2014
- Clinical tumour size and nodal status predict pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancerInternational Journal of Colorectal Disease, 2014
- T2 weighted signal intensity evolution may predict pathological complete response after treatment for rectal cancerEuropean Radiology, 2012
- Wait-and-See Policy for Clinical Complete Responders After Chemoradiation for Rectal CancerJournal of Clinical Oncology, 2011
- Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancerEuropean Radiology, 2011
- Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient dataThe Lancet Oncology, 2010
- Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2)Radiotherapy and Oncology, 2009
- Rectal Carcinoma: High-Spatial-Resolution MR Imaging and T2 Quantification in Rectal Cancer SpecimensRadiology, 2006
- Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation TherapyAnnals of Surgery, 2004